USFDA Releases New Guidance on AI in Medical Products
Incorporating Artificial Intelligence into Medical Products: The FDA’s Strategy On March 15, the U.S. Food and Drug Administration (FDA) released a comprehensive paper titled “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together.” This document outlines the FDA’s strategy for integrating artificial intelligence (AI) into medical products across its various […]
USFDA Releases New Guidance on AI in Medical Products Read More »










